GattaCo
1 known investors
GattaCo develops a blood collection device (A-PON) that uses passive elution to separate lab-quality liquid plasma from a self-collected finger-stick sample, which can then be mailed to a central lab for testing. The technology targets testing labs, clinical studies, and point-of-use settings, enabling remote blood collection without phlebotomists or centrifugation.
Digital HealthHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does GattaCo do?
- GattaCo develops a blood collection device (A-PON) that uses passive elution to separate lab-quality liquid plasma from a self-collected finger-stick sample, which can then be mailed to a central lab for testing. The technology targets testing labs, clinical studies, and point-of-use settings, enabling remote blood collection without phlebotomists or centrifugation.
- Who are GattaCo's investors?
- GattaCo's investors include Farvatn Venture.